Anthony L. Boral, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 9,900 shares at $48.21 ($481K) on 2017-08-09, disclosed to the SEC on 2017-08-11.
Open-market sale of $481k BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.79 | 100 | $5K | 1.0% |
| 2 | $48.21 | 3,085 | $149K | 30.9% |
| 3 | $48.21 | 3,085 | $149K | 30.9% |
| 4 | $49.30 | 1,815 | $89K | 18.6% |
| 5 | $49.30 | 1,815 | $89K | 18.6% |
| Total | $48.61 avg | 9,900 |
| $481K |
| 100% |
| Filing → |
| BPMC | SELL | 2020-09-21 | $1.9M | — | Filing → |
| BPMC | SELL | 2020-03-11 | $28K | — | Filing → |
| BPMC | SELL | 2019-12-19 | $1.5M | — | Filing → |